Women older than age 65 years who are overweight and have elevated levels of testosterone are at increased risk for developing coronary heart disease, insulin resistance, and other manifestations of metabolic syndrome.
Women older than age 65 years who are overweight and have elevated levels of testosterone are at increased risk for developing coronary heart disease, insulin resistance, and other manifestations of metabolic syndrome.
A multicenter study of 344 women between 65 and 98 years of age enrolled in the Cardiovascular Health Study measured levels of total and free testosterone by equilibrium dialysis. Cross-sectional analyses examined associations among total and free testosterone and metabolic syndrome, insulin resistance, and coronary heart disease.
Researchers found a stepwise increase in insulin resistance with increased levels of total (P=.003) and free (P=.02) testosterone and a corresponding decrease in Quantitative Insulin Sensitivity Check Index (P<.001 and P=.002, respectively). Adjusted models also found strong associations between high levels of both total and free testosterone and abdominal obesity and high fasting glucose. Finally, women in the top quartile of total testosterone levels had 3-fold greater odds than women in the bottom quartile of developing metabolic syndrome and 3-fold greater odds than those in the second quartile of developing coronary heart disease.
Patel SM, Ratcliffe SJ, Reilly MP, et al. J Clin Endocrinol Metab. E-pub October 21, 2009. doi:10.1210/jc.2009-0740.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More